MP09-Neuropharmacology of Pain
Precision Medicine / IBS-MP09
The main objectives of the group are to identify new pharmacological targets for pain treatment, to develop new experimental models for the evaluation of pain with translational value, to deepen the knowledge of the neurochemical mechanisms involved in pain, to develop new strategies for the evaluation and treatment of pain. pain in clinic, as well as the determination of various effects of melatonin.
Research lines
- EVALUATION OF PAIN AND ANALGESIC PROCEDURES IN HUMANS. RECEPTORS COUPLED TO PROTEINS G
- IMPLICATION OF SIGMA1 RECEPTORS IN PAIN PERCEPTION MECHANISMS: Behavioral and biochemical studies in somatic and visceral pain models.
- MOLECULAR MECHANISMS OF THE ANTI-OBESITY EFFECT OF MELATONIN IN THE OBESE AND DIABETIC RAT
Research networks
- CA23156 - European Network for Sigma-1 Receptor as a Therapeutic Opportunity (SIGMA-1EUROPE)
MIGUEL ANGEL TEJADA GIRALDEZ
MAKEYA ADDULJABBAR HASOUN
CARLOS GOMEZ-NAVAS
MIGUEL ANGEL HUERTA MARTINEZ
SERGIO CUESTA MARTINEZ
MIRIAM SANTOS KNIGHT
ESPERANZA DEL WELL GAVILAN
JOSE MANUEL TRAINS FERNANDEZ
EDUARDO FERNANDEZ SEGURA
RAFAEL GALVEZ MATEOS
RAFAEL GONZALEZ CANO
ANA MARIA JIMENEZ GARCIA
MARY IMMACULATE ROSA MONTES RAMIREZ
FRANCISCO RAFAEL NIETO LOPEZ
LEANDRO RUIZ LEYVA
MARIA DEL CARMEN RUIZ CANTERO
AHMAD AGIL ABDALLA
ANTONIA ARTACHO CORDON
FRANCISCO JAVIER CANIZARES GARCIA
MIGUEL CENDAN MARTINEZ CROSS
ENRIQUE JOSE COBOS DEL MORAL
Binging from Food to Alcohol: A Sequential Interaction Between Binging Behaviors in Male Wistar Rats
BIO-PROTOCOL, 2023;
Sigma-1 receptor agonism exacerbates immune-driven nociception: Role of TRPV1+nociceptors
BIOMEDICINE & PHARMACOTHERAPY, 2023;
FI: 7,5; Q1
Efficacy and Safety of Tetrodotoxin in the Treatment of Cancer-Related Pain: Systematic Review and Meta-Analysis
MARINE DRUGS, 2023;
FI: 5,4; Q1
Minocycline Prevents the Development of Key Features of Inflammation and Pain in DSS-induced Colitis in Mice
JOURNAL OF PAIN, 2023;
FI: 4; Q2
Peer review of teaching: using the nominal group technique to improve a program in a university setting with no previous experience
INTERNATIONAL JOURNAL FOR ACADEMIC DEVELOPMENT, 2023;
FI: 1,3; Q4
Dose-Dependent Effect of Melatonin on BAT Thermogenesis in Zucker Diabetic Fatty Rat: Future Clinical Implications for Obesity.
ANTIOXIDANTS, 2022;
FI: 7,675; D1
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022;
FI: 7,088; D1
Synthesis of tropane-based sigma(1) receptor antagonists with antiallodynic activity
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022;
FI: 7,088; D1
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors
JOURNAL OF MEDICINAL CHEMISTRY, 2022;
FI: 8,039; D1
Automated preclinical detection of mechanical pain hypersensitivity and analgesia
PAIN, 2022;
FI: 7,926; Q1
Caloric Restriction in Group-Housed Mice: Littermate and Sex Influence on Behavioral and Hormonal Data
FRONTIERS IN VETERINARY SCIENCE, 2021;
FI: 3,412; D1
Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high sigma(1) receptor affinity, antitumor and analgesic activity
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021;
FI: 6,514; D1
Calmodulin Supports TRPA1 Channel Association with Opioid Receptors and Glutamate NMDA Receptors in the Nervous Tissue
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021;
FI: 5,924; Q1
Discovery of a sigma(1) receptor antagonist by combination of unbiased cell painting and thermal proteome profiling
CELL CHEMICAL BIOLOGY, 2021;
FI: 8,116; Q1
Ca and Mg Concentrations in Spices and Growth of Commonly Sporulated and Non-Sporulated Food-Borne Microorganisms According to Marketing Systems
FOODS, 2021;
FI: 4,35; Q2
EST64454: a Highly Soluble sigma (1) Receptor Antagonist Clinical Candidate for Pain Management
JOURNAL OF MEDICINAL CHEMISTRY, 2020;
FI: 6,205; D1
Publisher: Sigma Receptors
FRONTIERS IN PHARMACOLOGY, 2020;
FI: 4,225; Q1
Publisher: Mechanisms and New Targets for the Treatment of Chronic Pain
FRONTIERS IN PHARMACOLOGY, 2020;
FI: 4,225; Q1
Melatonin Improves Mitochondrial Dynamics and Function in the Kidney of Zucker Diabetic Fatty Rats
JOURNAL OF CLINICAL MEDICINE, 2020;
FI: 3,303; Q1
Binge-Like, Naloxone-Sensitive, Voluntary Ethanol Intake at Adolescence Is Greater Than at Adulthood, but Does Not Exacerbate Subsequent Two-Bottle Choice Drinking
FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2020;
FI: 2,512; Q2
Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and sigma (1) receptor antagonists: Synthesis, receptor affinity, selectivity and antiallodynic activity
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019;
FI: 4,833; D1
A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer
PHARMACOLOGICAL RESEARCH, 2019;
FI: 5,574; D1
Sigma-1 Receptor Inhibition Reduces Neuropathic Pain Induced by Partial Sciatic Nerve Transection in Mice by Opioid-Dependent and - Independent Mechanisms
FRONTIERS IN PHARMACOLOGY, 2019;
FI: 3,845; Q1
Prevalence and risk factors associated with fatal adverse drug reactions among patients admitted at a Spanish teaching hospital
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019;
FI: 3,66; Q1
Modulation by Sigma-1 Receptor of Morphine Analgesia and Tolerance: Nociceptive Pain, Tactile Allodynia and Grip Strength Deficits During Joint Inflammation
FRONTIERS IN PHARMACOLOGY, 2019;
FI: 3,845; Q1
Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists.
PHARMACOLOGICAL RESEARCH, 2018;
FI: 4,897; D1
(+) - Methyl (1R, 2S) -2 - {[4- (4-Chlorophenyl) -4-hydroxypiperidin-1-yl] methyl} -1-phenylcyclopropanecarboxylate [(+) - MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties
JOURNAL OF MEDICINAL CHEMISTRY, 2018;
FI: 6,253; D1
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile
JOURNAL OF MEDICINAL CHEMISTRY, 2018;
FI: 6,253; D1
Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic sigma Receptor Ligands with Exocyclic Amino Moiety
JOURNAL OF MEDICINAL CHEMISTRY, 2018;
FI: 6,253; D1
Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling
CELL REPORTS, 2018;
FI: 8,032; Q1
Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia
NEUROPHARMACOLOGY, 2017;
FI: 5,012; D1
Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017;
FI: 9,661; D1
Paclitaxel-loaded hollow-poly (4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines
NANO RESEARCH, 2017;
FI: 7,354; D1
Effects of Tetrodotoxin in Mouse Models of Visceral Pain
MARINE DRUGS, 2017;
FI: 3,503; Q1
Roles for CD8 (+) T Cells and IL-10 in the Resolution of Paclitaxel-Induced Neuropathic Pain
JOURNAL OF NEUROSCIENCE, 2017;
FI: 5,988; Q1
Sigma-1 Receptor Agonism Promotes Mechanical Allodynia After Priming the Nociceptive System with Capsaicin
SCIENTIFIC REPORTS, 2016;
FI: 5,228; Q1
Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
SCIENTIFIC REPORTS, 2016;
FI: 5,228; Q1
Distinguishing subgroups among mu-opioid receptor agonists using Na +, K + -ATPase as an effector mechanism
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016;
FI: 2,73; Q2
Analysis of food advertising to children on Spanish television: probing exposure to television marketing
ARCHIVES OF MEDICAL SCIENCE, 2016;
FI: 1,812; Q2
Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE)
BMC PUBLIC HEALTH, 2016;
FI: 2,209; Q2
ACUTE CONFUSIONAL SYNDROME INDUCED BY MOXIFLOXACIN IN AN ELDERLY MAN
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015;
FI: 4,572; D1
Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats
JOURNAL OF PINEAL RESEARCH, 2015;
FI: 9,6; D1
Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research
CURRENT MEDICINAL CHEMISTRY, 2015;
FI: 3,853; D1
Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders
TRANSLATIONAL RESEARCH, 2015;
FI: 5,03; D1
The clinical heterogeneity of coenzyme Q (10) deficiency results from genotypic differences in the Coq9 gene
EMBO MOLECULAR MEDICINE, 2015;
FI: 8,665; D1
EVALUATION OF THERAPEUTIC POTENTIAL OF SIGMA-1 RECEPTORS IN ENDOMETRIOSIS USING COMPUTERIZED BEHAVIORAL MEASUREMENTS
Funder: UNIVERSITY OF GRANADA
File number: C-CTS-226-UGR23
Execution time: 01/01/2024 - 31/12/2026
IP: MIGUEL ANGEL TEJADA GIRALDEZ
BEHAVIOURAL CONSEQUENCES OF EARLY ALCOHOL EXPOSURE: INFLUENCE OF FOLIC ACID AND SELENIUM SUPPLEMENTATION TO RESTORE OXIDATIVE BALANCE
Funder: UNIVERSITY OF GRANADA
File number: C-CTS-307-UGR23
Execution time: 01/01/2024 - 31/12/2026
PI: CRUZ MIGUEL CENDAN MARTINEZ
Molecular mechanisms of cytoplasmic and organellar calcium modulation and Ca2+-dependent pathways in skeletal muscle in response to melatonin in vivo and in vitro (ZDF rats and human myoblast
Funder: STATE RESEARCH AGENCY
File number: PID2021-125900OB-I00
Execution time: 01/09/2022 - 31/08/2025
IP: AHMAD AGIL ABDALLA
Inhibition of the sigma-1 (σ1) receptor and the soluble epoxide hydrolase enzyme: a new strategy for the treatment of pain in rheumatoid arthritis
Funder: STATE RESEARCH AGENCY
File number: PID2021-123058NA-I00
Execution time: 01/09/2022 - 31/08/2025
PI: FRANCISCO RAFAEL NIETO LOPEZ
Searching for new measures of pain in animals to refine the development of analgesics (MOUSEdata)
Funder: UNIVERSITY OF GRANADA
File number: 63
Execution time: 01/01/2023 - 31/12/2023
IP: RAFAEL GONZALEZ CANO
Sigma-1 receptors; Endogenous opioid analgesia and neuroinflammation in rheumatoid arthritis
Funder: UNIVERSITY OF GRANADA
File number: B-CTS-642-UGR20
Execution time: 01/07/2021 - 30/06/2023
PI: FRANCISCO RAFAEL NIETO LOPEZ
Multimodal analgesia in rheumatoid arthritis: sigma-1 receptor inhibition to increase the therapeutic range of NSAIDs
Funder: COUNCIL OF ECONOMIC TRANSFORMATION, INDUSTRY, KNOWLEDGE AND UNIVERSITIES
File number: PY20_00132
Execution time: 04/10/2021 - 30/06/2023
PI: ENRIQUE JOSE COBOS DEL MORAL
Modulation of mitochondrial dynamics and endoplasmic reticulum stress in brown and renal adipose tissue in response to the anti-obesity effect of melatonin in obese and diabetic rats
Funder: UNIVERSITY OF GRANADA
File number: B-CTS-102-UGR20
Execution time: 01/06/2021 - 31/05/2023
IP: AHMAD AGIL ABDALLA
Immunotherapy and inhibition of the sigma-1 (σ1) receptor as a therapeutic strategy for pain relief in rheumatoid arthritis
Funder: PUBLIC FOUNDATION FOR BIOSANITARY RESEARCH OF ORIENTAL ANDALUCIA ALEJANDRO OTERO (FIBAO)
File number: INTRAIBS-2020-09
Execution time: 01/01/2021 - 31/12/2021
PI: FRANCISCO RAFAEL NIETO LOPEZ
Inhibition of the sigma-1 receptor: a new strategy for the treatment of postoperative pain
Funder: STATE RESEARCH AGENCY
File number: PID2019-108691RB-I00
Execution time: 01/06/2020 - 30/05/2024
PI: ENRIQUE JOSE COBOS DEL MORAL
Neurobiological and behavioral determinants of binge-type alcohol consumption in adolescent female and male rats: role of sigma-1 receptors and their potential use as pharmacological treatment
Funder: MINISTRY OF HEALTH
File number: PND-2020-049
Execution time: 01/01/2021 - 31/12/2023
PI: CRUZ MIGUEL CENDAN MARTINEZ
Evaluation of the Analgesic Efficacy of a New Transcutaneous Electromagnetic System in Pathologies Associated with Peripheral Neuropathic Pain
Funder: COUNCIL OF HEALTH
File number: PIN-0505-2016
Execution time: 01/01/2017 - 31/12/2018
PI: RAFAEL GALVEZ MATEOS
Phase III, randomized, double-blind, placebo-comparative study to evaluate the efficacy and safety of a single intra-articular injection of RTX-GRT7039 in adult patients with pain derived from gonarthrosis.
Financier: GRÜNENTHAL GMBH
Type of test: CLINICAL TRIAL WITH DRUGS
Execution time: 23/11/2022 - 30/09/2024
PI: RAFAEL GALVEZ MATEOS
Randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of BIIB074 in subjects with lumbosacral radiculopathy neuropathic pain
Funder: CONVERGENCE PHARMACEUTICALS LIMITED
Type of test: COMMERCIAL CLINICAL TRIAL
Execution time: 20/04/2017 - 30/05/2018
PI: RAFAEL GALVEZ MATEOS
An Uncontrolled, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Funder: BIOGEN IDEC LIMITED
Type of test: COMMERCIAL CLINICAL TRIAL
Execution time: 08/11/2017 - 30/04/2019
PI: RAFAEL GALVEZ MATEOS
Double-blind, placebo-controlled, randomized, dose-finding trial to determine the safety and efficacy of three dose levels of EMA401 in reducing the 24-hour mean pain intensity score in patients with postherpetic neuralgia (EMPHENE)
Funder: NOVARTIS FARMACEUTICA, SA
Type of test: COMMERCIAL CLINICAL TRIAL
Execution time: 21/07/2017 - 30/09/2019
PI: RAFAEL GALVEZ MATEOS